Millennium Management’s Sinovac Biotech, Ltd SVA Stock Holding History

Millennium Management’s Portfolio SVA Stock Details SVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-10,195	Closed	-$76K	–	4580
2018 Q2	$76K	Buy	+10,195	New	+$80.2K	﹤0.01%	3678
2017 Q4	–	Sell	-58,083	Closed	-$409K	–	4353
2017 Q3	$409K	Sell	58,083 -7,364	-11%	-$50.3K	﹤0.01%	2933
2017 Q2	$442K	Buy	65,447 +9,595	+17%	+$52.6K	﹤0.01%	2867
2017 Q1	$320K	Buy	+55,852	New	+$323K	﹤0.01%	3018
2016 Q1	–	Sell	-14,400	Closed	-$82K	–	4044
2015 Q4	$82K	Sell	14,400 -14,100	-49%	-$75.9K	﹤0.01%	3266
2015 Q3	$145K	Buy	+28,500	New	+$151K	﹤0.01%	3204
2015 Q1	–	Sell	-31,700	Closed	-$166K	–	4593
2014 Q4	$166K	Sell	31,700 -9,708	-23%	-$49.5K	﹤0.01%	3686
2014 Q3	$199K	Sell	41,408 -42,526	-51%	-$228K	﹤0.01%	3439
2014 Q2	$473K	Sell	83,934 -23,019	-22%	-$140K	﹤0.01%	2620
2014 Q1	$770K	Buy	+106,953	New	+$708K	﹤0.01%	2381
2013 Q4	–	Sell	-29,539	Closed	-$177K	–	4177
2013 Q3	$177K	Buy	29,539 +1,541	+6%	+$7.37K	﹤0.01%	3134
2013 Q2	$110K	Buy	+27,998	New	+$104K	﹤0.01%	2860

Other funds holding SVA

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

NAH

Neumann Advisory (HK) Central, Hong Kong $356M AUM 37.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SSP

Sapphire Star Partners Redmond, Washington $74.7M AUM 5.87% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

YMRC

Yorktown Management & Research Company Forest, Virginia $120M AUM 52.72% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

FIM

Freedom Investment Management Hartford, Connecticut $337M AUM 22.95% 1-Year Est. Return

Millennium Management's SVA Position: Q3 2018 in Review

Millennium Management sold out of Sinovac Biotech, Ltd (SVA) in Q3 2018, closing a stake of 10,195 shares — an estimated $76K sold.

Millennium Management first reported a position in SVA in Q2 2013 and held it in 12 quarters. The position peaked at $770K in Q1 2014. 28 funds tracked by Wall St. Rank hold SVA as of Q3 2018.

Millennium Management reported no remaining Sinovac Biotech, Ltd position as of Q3 2018 after selling out during the quarter.
Millennium Management sold 10,195 Sinovac Biotech, Ltd shares in Q3 2018, an estimated $76K.
Millennium Management first reported a position in Sinovac Biotech, Ltd in Q2 2013 and held it in 12 quarters.
Millennium Management's Sinovac Biotech, Ltd position peaked at $770K in Q1 2014.
28 funds tracked by Wall St. Rank held Sinovac Biotech, Ltd as of Q3 2018.

Based on Millennium Management's 13F filing for Q3 2018, filed 14 Nov 2018.